
Robert Duane Davis MD
Adult Cardiac Surgery, Aortic Surgery, Cardiopulmonary Transplantation, Cardiovascular Surgery
Chief Physician Executive Institutes, Adventhealth CFD
2415 N Orange AvenueSuite 700Orlando, FL 32804
Overview of Dr. Davis
Dr. Robert Davis is a cardiothoracic surgeon based in Orlando, FL, specializing in thoracic transplantation and surgical management of CTEPH. He completed his medical education at the David Geffen School of Medicine at UCLA, followed by a surgery residency and thoracic surgery fellowship at Duke University Hospital. He also holds an MBA in Health Sector Management from Duke University. Dr. Davis has contributed to several clinical trials and has authored multiple publications in reputable journals, with particular focus on lung transplantation and related surgical techniques. His professional honors include membership in prestigious societies such as Tau Beta Pi and Alpha Omega Alpha, and he is a Fellow of the American College of Surgeons. He is the Chief Physician Executive for the Institutes at Adventhealth (HLVI, Cancer, Neuro-sciences, Digestive diseases, Orthopedics and Transplant).
Education & Training
Duke UniversityM.B.A, Health Sector Management, 2007 - 2008
Duke University HospitalFellowship, Thoracic Surgery - Independent, 1989 - 1993
Duke University HospitalResidency, Surgery, 1985 - 1989
David Geffen School of Medicine at UCLAClass of 1984
Stanford UniversityB.S., Chemical Engineering, 1976 - 1980
Certifications & Licensure
FL State Medical License 2015 - 2027
NC State Medical License 1992 - 2018
VA State Medical License 2006 - 2018
MO State Medical License 1993 - 2016
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2015-2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2016
- Tau Beta Pi - engineering honor society (top 5%)
Clinical Trials
- Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs Start of enrollment: 2011 May 01
- RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol Start of enrollment: 2011 Sep 01
Publications & Presentations
PubMed
- 25 citationsTransplantation, bridging, and support technologies in pulmonary hypertension.Laurent Savale, Alberto Benazzo, Paul Corris, Shaf Keshavjee, Deborah Jo Levine
The European Respiratory Journal. 2024-10-01 - 14 citationsEx vivo lung perfusion in donation after circulatory death: A post hoc analysis of the Normothermic Ex Vivo Lung Perfusion as an Assessment of Extended/Marginal Donors...Doug A Gouchoe, Pablo G Sanchez, Jonathan D'Cunha, Christian A Bermudez, Mani A Daneshmand
The Journal of Thoracic and Cardiovascular Surgery. 2024-09-01 - 4 citationsReflux Surgery in Lung Transplantation: A Multicenter Retrospective Study.Cynthia L Green, Brian C Gulack, Shaf Keshavjee, Lianne G Singer, Kenneth McCurry
The Annals of Thoracic Surgery. 2023-04-01
Journal Articles
- Transplant Size Mismatch In Restrictive Lung DiseaseGanapathi A.M.; Mulvihill M.S.; Englum B.R.; Speicher P.J.; Gulack B.C.; Osho A.A.; Yerokun B.A.; Snyder L.R.; Davis R.D.; Hartwig M.G, Transplant International, 1/1/2017
- Psychosocial Predictors of Mortality Following Lung TransplantationSmith PJ; Blumenthal JA; Trulock EP; Freeland KE; Carney RM; Davis RD; Hoffman BM; Palmer SM, American Journal of Transplantation, 1/1/2016
- Economic Outcomes of Extracorporeal Membrane Oxygenation With and Without Ambulation as a Bridge to Lung TransplantationBain JC; Turner DA; Rehder KJ; Eisenstein EL; Davis RD; Cheifetz IM; Zaas DW, Respiratory Care, 1/1/2016
Books/Book Chapters
Abstracts/Posters
- Factors Predicting Survival in Early Lung RetransplantationA. A. Osho, S. A. Hirji, B. C. Gulack, A. M. Ganapathi, R. D. Davis, M. G. Hartwig, ISHLT, 1/1/2015
- Impact of Repeated Mismatch Human Leukocyte Antigen on the Outcome of Lung RetransplantationH. Wang, L. Wan, Q. yang, W. E. Hanshew, R. D. Davis, D. Chen, ISHLT, 1/1/2015
- Lung Compliance During Ex-Vivo Lung Perfusion Predicts Early Post Transplant OutcomesP. G. Sanchez, G. J. Bittle, E. Cantu, III, F. D’Ovidio, M. Weyant, R. D. Davis, B. P. Griffith, ISHLT, 1/1/2015
Grant Support
- Result Trial-Reflux Surgery In Lung TransplantationNational Heart, Lung, And Blood Institute2010–2011
- Mechanisms Causing Pulmonary Xenograft InjuryNational Heart, Lung, And Blood Institute1998–2004
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Massachusetts Blue Care Elect PPO
BCBS North Carolina BlueOptions PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Carelink Health Plans PPO
First Choice
First Health PPOGreat West PPO
Harvard Pilgrim HMO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Providence Health System Personal Option
Tufts Health Plan PPO
UniCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









